Why biotech and drug stocks are rallying even though the rest of the market is hurting

marketwatch.com/story/why-biotech-and-drug-stocks-are-on-the-mend-even-though-the-rest-of-the-market-is-hurting-739d7317

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded away.

This story appeared on marketwatch.com, 2025-11-19 14:40:00.
The Entire Business World on a Single Page. Free to Use →